Compounds > 3,4-dihydroxyphenylethanol
Page last updated: 2024-08-25

3,4-dihydroxyphenylethanol and cyclin d1

3,4-dihydroxyphenylethanol has been researched along with cyclin d1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Corona, G; Deiana, M; Dessì, MA; Incani, A; Spencer, JP; Vauzour, D1
Bonofiglio, M; Bonofiglio, R; Cifarelli, RA; Gigliotti, P; La Russa, A; Leone, F; Lofaro, D; Lupinacci, S; Perri, A; Perri, E; Toteda, G; Vizza, D1
Akrami, S; Onsori, H; Rahmati, M; Sani, NS1

Other Studies

3 other study(ies) available for 3,4-dihydroxyphenylethanol and cyclin d1

ArticleYear
Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1.
    Molecular nutrition & food research, 2009, Volume: 53, Issue:7

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin D1; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phenylethyl Alcohol; Phosphorylation

2009
High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
    Journal of endocrinological investigation, 2017, Volume: 40, Issue:2

    Topics: Adenocarcinoma, Follicular; Antioxidants; Apoptosis; Blotting, Western; Carcinoma, Papillary; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Humans; Phenylethyl Alcohol; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thyroid Neoplasms; Tumor Cells, Cultured

2017
A Comparison of the Anti-Cancer Effects of Free and PLGA-PAA Encapsulated Hydroxytyrosol on the HT-29 Colorectal Cancer Cell Line.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:2

    Topics: Acrylic Resins; Antineoplastic Agents; Capsules; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Nanoparticles; Phenylethyl Alcohol; Polyesters; Polyglycolic Acid; Structure-Activity Relationship; Tumor Cells, Cultured

2022